SELE and myeloid leukemia: Based on this and the known upregulation of E-selectin observed on BM vessels adjacent to the leukemic cell [9, 11–13], we have developed a novel approach to efficiently redirect NK cells to the AML niche, which may be explored to improve response rates of adoptive NK cell immunotherapy against myeloid leukemia.